End of an Era: Reduced Severity of Tricuspid Regurgitation in Cardiac Transplant Recipients Managed with Molecular Diagnostic Testing

Purpose null A well-established complication of right ventricular endomyocardial biopsy (EMB) used for the diagnosis of acute cellular rejection is damage to the tricuspid valve and subsequent tricuspid regurgitant flow. Since the advent of Molecular Diagnostic Testing (MDT) as a screening test for determining which patients require EMB, the need for EMB at our center has decreased significantly. We hypothesized that the severity of tricuspid...